1. UPF1 increases amino acid levels and promotes cell proliferation in lung adenocarcinoma via the eIF2α-ATF4 axis
- Author
-
Lei Fang, Huan Qi, Peng Wang, Shiqing Wang, Tianjiao Li, Tian Xia, Hailong Piao, and Chundong Gu
- Subjects
Lung Neoplasms ,General Veterinary ,Eukaryotic Initiation Factor-2 ,Adenocarcinoma of Lung ,General Medicine ,Activating Transcription Factor 4 ,General Biochemistry, Genetics and Molecular Biology ,Trans-Activators ,Humans ,RNA, Messenger ,General Pharmacology, Toxicology and Pharmaceutics ,Amino Acids ,RNA Helicases ,Research Article ,Cell Proliferation - Abstract
Up-frameshift 1 (UPF1), as the most critical factor in nonsense-mediated messenger RNA (mRNA) decay (NMD), regulates tumor-associated molecular pathways in many cancers. However, the role of UPF1 in lung adenocarcinoma (LUAD) amino acid metabolism remains largely unknown. In this study, we found that UPF1 was significantly correlated with a portion of amino acid metabolic pathways in LUAD by integrating bioinformatics and metabolomics. We further confirmed that UPF1 knockdown inhibited activating transcription factor 4 (ATF4) and Ser51 phosphorylation of eukaryotic translation initiation factor 2α (eIF2α), the core proteins in amino acid metabolism reprogramming. In addition, UPF1 promotes cell proliferation by increasing the amino-acid levels of LUAD cells, which depends on the function of ATF4. Clinically, UPF1 mRNA expression is abnormal in LUAD tissues, and higher expression of UPF1 and ATF4 was significantly correlated with poor overall survival (OS) in LUAD patients. Our findings reveal that UPF1 is a potential regulator of tumor-associated amino acid metabolism and may be a therapeutic target for LUAD.
- Published
- 2022